Highest-materiality recent filing
Appointed Tru Golf Canada as exclusive master distributor for 5-year term across Indigenous communities in Canada, Thompson Okanagan BC, and Hard Rock opportunities in Oklahoma and Florida.
TruGolf posts August 2026 investor presentation; no new financials
TruGolf Holdings (TRUG) posted its August 2026 corporate presentation on its website on Aug 24, 2026.
TRUG receives Nasdaq equity non-compliance notice; shares converted from Series A preferred
Nasdaq notice Aug 19: stockholders' equity $2,060,281 as of Jun 30, below $2.5M minimum required by Rule 5550(b)(1)(A).
TruGolf acquires Polymath Research via amalgamation; issues Series C preferred and $5M financing
Amalgamation to acquire Polymath Research Inc.; consideration: 19.9% of Class A common stock plus Series C preferred based on $140M reference amount.
TruGolf Holdings appoints Steven Passey as CFO effective May 15, 2026
Initial base salary $225,000/yr for first 3 months, then increases to $250,000/yr.
TruGolf board member Limbers resigns; Brenner Adams appointed director, exits CGO role
Shaun Limbers resigned from Board on March 16, 2026, not due to any disagreement.
TruGolf completes redomestication from Delaware to Nevada
Redomestication effective March 10, 2026; Nevada charter and bylaws adopted.
Redomestication from Delaware to Nevada approved: 6,228,794 for, 161,758 against.
TruGolf repurchases 423,402 shares at $0.7552 avg; $1.67M remains under program
Repurchased 423,402 shares of Class A common stock at average price $0.7552 per share, including fees and commissions.
TruGolf repurchases 249,000 shares under $2M buyback program
Repurchased 249,000 shares at avg. price $0.8535 per share through Jan 31, 2026.
TruGolf sets Feb 17 annual meeting; seeks approval for redomestication to Nevada and share increase
Annual meeting scheduled for February 17, 2026.
TruGolf receives Nasdaq delinquency notice for missing annual meeting deadline
Violated Nasdaq Listing Rule 5620(a) and 5810(c)(2)(G) by not holding annual meeting within 12 months of fiscal year-end.
Nasdaq confirmed compliance with Equity Rule (5550(b)(1)) and minimum market value of publicly held securities as of August 1, 2025.
TruGolf regains Nasdaq compliance; completes debt conversions and warrant exercise
Regained minimum bid price compliance on July 17, 2025, as confirmed by Nasdaq Panel.
TruGolf converts $3.94M PIPE notes to preferred stock, receives $5M from warrant exercise
$3,938,311 of PIPE convertible notes exchanged for 3,938.311 shares of Series A Preferred Stock.
TruGolf Holdings files 1-for-50 reverse stock split effective June 23, 2025
Reverse stock split ratio: 1-for-50; effective 12:01 a.m. ET on June 23, 2025.
TruGolf gets Nasdaq temporary exception to July 2025; shareholders approve share increase to 650M
Nasdaq Panel grants temporary exception: bid price compliance by July 8, 2025; MVPHS and equity compliance by July 30, 2025.
TruGolf amends convertible note terms; allows $2M buyback, seeks 650M authorized shares
Reduced required reserve for Series A Preferred conversion; increased authorized shares sought from 500M to 650M.
TruGolf enters $20M equity purchase facility; shares at 93% of market price
Up to $20M in newly issued Class A common stock may be sold to institutional investor under EPFA.
TruGolf receives Nasdaq notice for MVPHS and bid price non-compliance; hearing May 15
Received Nasdaq notice on May 7, 2025, for failure to regain compliance with minimum MVPHS ($15M) and $1 bid price requirements.
TruGolf restructures $15.5M PIPE notes/warrants into Series A preferred; converts $3.9M notes
Exchanged PIPE warrants for 1,885 shares of Series A preferred stock and a warrant for 37,033 Series A preferred shares.
TruGolf receives Nasdaq delisting notice for equity non-compliance; plans appeal
Nasdaq determined TruGolf failed to maintain stockholders' equity of at least $10M by March 31, 2025.
TruGolf expects record 2024 sales of ~$22.5M; 2H EBITDA >$2.2M, above guidance
2024 sales expected ~$22.5M, a new record; 2H EBITDA >$2.2M, well above $1.1-1.5M guidance.
TruGolf extends Nasdaq compliance waiver deadlines to Feb 28, Apr 30
Convertible note holders extended waiver for listing compliance to February 28, 2025 (from Jan 15).
TruGolf issues additional $2.8M senior convertible notes, 10% OID, conversion prices $2.00/$2.50
January 8, 2025: PIPE investor exercised option for $2,800,000 principal of additional senior convertible notes; net proceeds $2,520,000 after 10% OID.
TruGolf issues additional $2.1M senior convertible notes; $3.25M of original PIPE notes converted
Issued $2.1M principal of senior convertible notes on Dec 16, 2024, gross proceeds $1.89M after 10% OID.
TruGolf Q3 sales up 82% YoY to $6.24M; EPS $0.00, EBITDA $1.1M; raises FY guidance
Third quarter sales of $6,236,795, up 82% vs Q3 2023; EPS $0.00.
TruGolf receives two Nasdaq notices: bid price below $1 and MVPHS under $15M
On Nov 5, 2024, Nasdaq notified TruGolf that its bid price was below $1 for 30 consecutive business days, triggering a 180-day compliance period ending May 5, 2025.
TruGolf receives Nasdaq delisting notice for negative stockholders' equity of ($10.5M)
Nasdaq notified TruGolf on Aug 19, 2024, that stockholders' equity was ($10,508,104) as of June 30, 2024, below the $10M minimum.
TruGolf receives Nasdaq deficiency notice for late Q1 10-Q filing
Received deficiency letter on July 15, 2024 for failing to file Q1 2024 Form 10-Q on time.
TruGolf, Inc. 2023 net loss $10.3M vs $0.96M; going concern doubt raised
Net loss of $10,283,109 (revenue $20,583,851) vs 2022 loss of $956,841 (revenue $20,227,331).
TruGolf shareholders approve PIPE conversion and warrant issuance at special meeting
Proposal 1 to approve PIPE conversion shares and warrant shares: 50,234,375 for, 22,106 against, 3 abstentions.
TruGolf Holdings dismisses MaloneBailey, engages Haynie as new independent auditor
Dismissed MaloneBailey as auditor on Feb 19, 2024; engaged Haynie & Company to audit FY ending Dec 31, 2023.
TruGolf enters up to $15.5M PIPE financing with convertible notes and warrants
Initial closing of $4.65M aggregate principal convertible notes at 10% OID for $4.185M gross proceeds; up to $15.5M total.
TruGolf completes de-SPAC merger with Deep Medicine, begins trading on Nasdaq under TRUG
Closed merger on Jan 31, 2024; implied equity value for TruGolf $80M; DMAQ changed name to TruGolf Holdings, Inc.
Stockholders approved combination at Jan 19, 2024 meeting; closing occurred Jan 31, 2024.
Deep Medicine Acquisition stockholders approve business combination with TruGolf
Stockholders approved the NTA proposal, business combination, charter, governance, equity incentive plan, director election, and Nasdaq proposals at Jan 19 special meeting.
Deep Medicine Acquisition Corp. amends TruGolf merger terms and secures $11M PIPE financing
Amendment increases Class B voting rights from 10 to 25 votes per share and reduces post-closing board from 7 to 5 members.
Up to $8M in convertible notes with 10% OID across three tranches; $2.11M funded at close of Business Combination.
DMAQ files S-4 for merger with TruGolf; Q4 2023 close expected
DMAQ filed Form S-4 on July 31, 2023 for proposed business combination with TruGolf, a golf simulator manufacturer.
Deep Medicine Acquisition amends TruGolf merger: earnout shares post-closing, $10/share price fixed
Earnout shares to be issued after Closing if milestones met, not at Closing and put in escrow.
Agreements with six unaffiliated third parties covering max 514,773 shares of Class A common stock.
Deep Medicine shareholders extend business combination deadline to Jan 29, 2024; ~$2.9M redeemed
Stockholders approved charter amendment moving deadline from July 29, 2023 to January 29, 2024.
Non-redemption agreements with two unaffiliated parties for max 22,606 shares; Sponsor to transfer up to 8,138 Founder Shares upon business combination.
Deep Medicine Acquisition Corp. enters merger agreement with TruGolf valued at up to $125M
Total merger consideration up to $125M: $80M base plus up to $45M in restricted shares subject to earnout milestones.
Deep Medicine Acquisition Corp. to merge with TruGolf at $125M enterprise value
Implied enterprise value of $125M, including up to $45M contingent consideration.
Deep Medicine Acquisition transfers listing to Nasdaq Capital Market to cure non-compliance
Approved by Nasdaq on February 15, 2023; effective February 17, 2023.
Received Nasdaq notice on Jan 22, 2023 for failure to meet minimum 1,100,000 publicly held shares (Listing Rule 5450(b)(2)).
DMAQ shareholders approve extension to July 2023; 93% of public shares redeemed
11,819,790 public shares redeemed at ~$10.24/share, removing ~$121M from trust.
Deep Medicine sets special meeting Dec 23, 2022; nomination deadline Dec 1
Special meeting in lieu of 2022 annual meeting scheduled for or about December 23, 2022.
On May 1, 2026, TruGolf Holdings, Inc. (the “Company”) entered into an employment letter (the “Employment Letter”) with Steven Passey to serve as the Company’s Chief Financial Officer effective May 15, 2026.
Christopher Jones, Shaun Limbers, Humphrey Polanen, AJ Redmer, and Riley Russell were appointed as directors of the Company.
Christopher Jones, Shaun Limbers, Humphrey Polanen, AJ Redmer, and Riley Russell were appointed as directors of the Company.
Christopher Jones, Shaun Limbers, Humphrey Polanen, AJ Redmer, and Riley Russell were appointed as directors of the Company.
Christopher Jones, Shaun Limbers, Humphrey Polanen, AJ Redmer, and Riley Russell were appointed as directors of the Company.
Mr. Christopher Jones was appointed Chief Executive Officer, President and Chairman of the Board of the Company.
Mr. Lindsay Jones will serve as the Chief Financial Officer of the Company.
To fill the vacancy created by Mr. Fong’s and Mr. Hamer’s resignation, on October 15, 2022, the Board appointed John Chiang to serve as a member of the Board and as the chairman of each of the audit committee and compensation committee of the Board, effective immediately.
On October 15, 2022, each of Bryant E. Fong and Marc A. Hamer informed the Board of Directors (the “ Board ”) of the Company, of his intention to resign as a director of the Company effective immediately.
On October 15, 2022, each of Bryant E. Fong and Marc A. Hamer informed the Board of Directors (the “ Board ”) of the Company, of his intention to resign as a director of the Company effective immediately.
Max materiality 1.00 · Median 0.68 · Most common event other_material